ACIP is recommending that adults aged 50 to 59 years who are at increased risk for severe RSV disease receive a single dose of an RSV vaccine.

Exclusive use of e-cigarettes or dual use with low cigarette usage is linked to lower levels of tobacco-specific carcinogens.

Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.

Abortion bans have affected US pulmonary and critical care physicians, resulting in care delays and restrictions, especially for low-income patients.

Topical deep delivery of corticosteroids into the sinonasal cavity improves symptoms and sleep in patients with chronic rhinosinusitis.

ACIP recommends pentavalent meningococcal vaccine Penmenvy (meningococcal Groups A, B, C, W, and Y vaccine) for individuals 10 through 25 years of age.

Living in a neighborhood with persistent poverty was associated with higher overall cancer mortality in children.

The HHS will invest $176 million in a mRNA vaccine from Moderna meant to protect against an avian influenza pandemic.

Most new emphysema is propagated in high mechanically affected lung regions rather than in lung areas with small airways disease.

The CDC’s ACIP updated guidance on pneumococcal vaccination, recommending a single dose of PCV for all adults aged 50 years and older.

Adult incident asthma is associated with a lower number of daily steps, suggesting that exercise may modify asthma risk.

The DOJ has accused CHEST and other medical journals of scientific bias, demanding responses to a list of questions by May 2, 2025.